top of page

FDA Shortages September/October 2021


You are subscribed to Drug Shortages for U.S. Food and Drug Administration. This information has recently been updated, and is now available.

  • FDA Drug Shortages

    • Atropine Sulfate Ophthalmic Ointment (Updated - Resolved)

    • Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)

    • Chlordiazepoxide Hydrochloride Capsules (Updated - Currently in Shortage)

    • Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)

    • Dexmedetomidine Injection (Updated - Currently in Shortage)

    • Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)

    • Famotidine Tablets (Updated - Currently in Shortage)

    • Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)

    • Histreline Acetate Implant (New - Discontinuation)

    • Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)

    • Ketamine Injection (Updated - Currently in Shortage)

    • Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)

    • Loxapine Capsules (Updated - Currently in Shortage)

    • Nefazodone Hydrochloride Tablets (Updated - Currently in Shortage)

    • Nizatidine Capsules (Updated - Currently in Shortage)

    • Propofol Injectable Emulsion (Updated - Currently in Shortage)

    • Sulfasalazine Tablets (Updated - Currently in Shortage)

    • Vecuronium Bromide for Injection (Updated - Currently in Shortage)

    • Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)

    • Dopamine Hydrochloride Injection (Updated - Currently in Shortage)

    • Heparin Sodium and Sodium Chloride 0.9% Injection (Updated - Currently in Shortage)

    • Mannitol Injection (New - Currently in Shortage)



25 views0 comments

Recent Posts

See All
bottom of page